WHO ICTRP trial
A Multi-center, Randomized, Controlled Clinical Trial of Pegylated interferon…
ChiCTR-PPC-15006199 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-PPC-15006199 |
|---|---|
| Public title | A Multi-center, Randomized, Controlled Clinical Trial of Pegylated interferon alpha-2a (40KD) Plus Ribavirin With or Without Vitamin D in Chronic Hepatitis C |
| Scientific title | A Multi-center, Randomized, Controlled Clinical Trial of Pegylated interferon alpha-2a (40KD) Plus Ribavirin With or Without Vitamin D in Chronic Hepatitis C |
| Primary sponsor | The First Affiliated Hospital of Xinjiang Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | Chronic hepatitis C |
| Interventions | Experimental:vitamin D supplementation with pegylated interferon + ribavirin (PegIFN/RBV);Control:pegylated interferon + ribavirin (PegIFN/RBV) |
| Registration date | Apr 2, 2015 |
| Target size | Experimental:112;Control:112 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: